(Q39691784)

14 September 2017

title

Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma (English)

1 reference

14 September 2017

Janina Seznec

1

1 reference

14 September 2017

Björn Silkenstedt

series ordinal

2

1 reference

14 September 2017

Ulrike Naumann

series ordinal

3

1 reference

14 September 2017

language of work or name

1 reference

17 June 2010

1 reference

Journal of Neuro-Oncology

14 September 2017

published in

1 reference

14 September 2017

volume

101

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

365-377

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Molecular mechanisms of glioma cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Mithramycin A sensitizes cancer cells to TRAIL-mediated apoptosis by down-regulation of XIAP gene promoter through Sp1 sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

TGF-beta-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

PCTAIRE3: a putative mediator of growth arrest and death induced by CTS-1, a dominant-positive p53-derived synthetic tumor suppressor, in human malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Alkylphosphocholine-induced glioma cell death is BCL-X(L)-sensitive, caspase-independent and characterized by massive cytoplasmic vacuole formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Adenoviral natural born killer gene therapy for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

p53 and its family members -- reporter genes may not see the difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Sp1, but not Sp3, functions to mediate promoter activation by TGF-beta through canonical Sp1 binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Sp1 is involved in H2O2-induced PUMA gene expression and apoptosis in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

Transcriptional regulation of ULBP1, a human ligand of the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0266-X

The G-C specific DNA binding drug, mithramycin, selectively inhibits transcription of the C-MYC and C-HA-RAS genes in regenerating liver

21 January 2018

1 reference

12 December 2020

Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.

1 reference

12 December 2020

MICA/NKG2D-mediated immunogene therapy of experimental gliomas.

1 reference

12 December 2020

Mechanisms of malignant glioma immune resistance and sources of immunosuppression

1 reference

12 December 2020

Survivin in glioblastomas. Protein and messenger RNA expression and comparison with telomerase levels

1 reference

12 December 2020

Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo

1 reference

12 December 2020

Inhibition of p53-mediated transcriptional responses by mithramycin A.

1 reference

12 December 2020

Mithramycin represses MDR1 gene expression in vitro, modulating multidrug resistance

1 reference

12 December 2020

Transcriptional regulation of MICA and MICB: A novel polymorphism in MICB promoter alters transcriptional regulation by Sp1

1 reference

12 December 2020

CD95 ligand: lethal weapon against malignant glioma?

1 reference

12 December 2020

10.1007/S11060-010-0266-X

Identifiers

DOI

1 reference

14 September 2017

1 reference